跳转至内容

尊敬的客户:

目前国际形势复杂多变,关税政策尚不明朗,这可能对我们的产品价格产生一定影响。在此情况下,我们希望就订单事宜与您进行友好沟通。

基于当前的不确定性,如果您选择在此期间下单,我们将保留根据实际情况调整价格的权利。同时,我们也理解市场变化可能给您带来的困扰,因此如果在订单实际发货前因关税政策变动导致价格出现较大波动,默克将与您进行协商讨论并视情况对订单进行调整或取消。

Merck
CN
所有图片(1)

主要文件

20832-U

Supelco

ORBO 402 Tenax® TA 经过特殊处理(35/60),100/50mg

W,W,W separators, O.D. × L 8 mm × 100 mm, pkg of 50 ea

别名:

ORBO Tenax® TA

登录查看公司和协议定价

选择尺寸

500 G
¥1,018.94
2.5 KG
¥3,275.29

¥1,018.94


预计发货时间2025年7月01日详情


获取大包装报价

选择尺寸

变更视图
500 G
¥1,018.94
2.5 KG
¥3,275.29

About This Item

UNSPSC代码:
12190000
NACRES:
NB.24

¥1,018.94


预计发货时间2025年7月01日详情


获取大包装报价

物料

W,W,W separators

质量水平

Agency

NIOSH 2507,2545,7905
OSHA 43

产品线

ORBO

组成

Bed A, 100 mg
Bed B, 50 mg

包装

pkg of 50 ea

制造商/商品名称

ORBO 402

技术

active air sampling: suitable

外径 × 长度

8 mm × 100 mm

基质

Tenax TA (specially treated)

正在寻找类似产品? 访问 产品对比指南

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
S9627S564013464
硫酸钠 BioXtra, ≥99.0%

S6547

硫酸钠

硫酸钠 ReagentPlus®, ≥99.0%

S9627

硫酸钠

硫酸钠 ≥99.0%, suitable for plant cell culture

S5640

硫酸钠

硫酸钠 puriss., meets analytical specification of Ph. Eur., BP, USP, anhydrous, 99.0-100.5% (calc. to the dried substance)

13464

硫酸钠

form

powder

form

powder

form

powder

form

crystalline

assay

≥99.0%

assay

≥99.0%

assay

≥99.0%

assay

99.0-100.5% (calc. to the dried substance)

solubility

H2O: 1 M, clear, colorless

solubility

-

solubility

water: soluble 1 g/10 mL

solubility

-

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

density

2.68 g/mL at 25 °C (lit.)

density

2.68 g/mL at 25 °C (lit.)

density

2.68 g/mL at 25 °C (lit.)

density

2.68 g/mL at 25 °C (lit.)

cation traces

Al: ≤0.0005%, Cu: ≤0.0005%, K: ≤0.005%, NH4+: ≤0.05%, Zn: ≤0.001%, Ca: ≤0.005%, Mg: ≤0.005%, Fe: ≤0.0005%, Pb: ≤0.001%

cation traces

-

cation traces

-

cation traces

As: ≤2 mg/kg, Ca: ≤50 mg/kg, Fe: ≤50 mg/kg, Mg: ≤50 mg/kg, Zn: ≤300 mg/kg

一般描述

ORBO 402 Tenax® TA吸附管(特别处理,35/60,100/50 mg)用于气体或蒸汽采样。它是装填双层填充床的玻璃管,双层填充床采用相同的选择性吸附剂,中间由玻璃棉或泡沫隔开。双层设计使较少一层填充床可作为后备,捕获因过载而穿透前一层填充床的样品。

适用气相色谱-质谱(GC-MS)仪器,常用于呼吸分析。 [1]

应用

ORBO 402 Tenax® TA吸附管(特别处理,35/60,100/50 mg)可作为吸附剂采集空气样品,用于GC/MS法测定环境中的微量苯。 [2]

法律信息

ORBO is a trademark of Sigma-Aldrich Co. LLC
Tenax is a registered trademark of Buchem B.V.

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Gloves

  • 技术规格说明书

  • 历史批次信息供参考:

    分析证书(COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

    如需帮助,请联系 客户支持

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Determination of benzene at trace levels in air by a novel method based on solid-phase microextraction gas chromatography/mass spectrometry.
    Alessandro S, et al.
    Rapid Communications in Mass Spectrometry, 15, 2404-2408 (2001)
    Low-cost desorption unit coupled with a gold nanoparticles gas sensors array for the analysis of volatile organic compounds emitted from the exhaled breath (gastric cancer and control samples.
    Cristhian Manuel D, et al.
    Microelectronic Engineering, 237, 111483-111483 (2021)
    K Flo et al.
    Scandinavian journal of clinical and laboratory investigation, 55(8), 715-721 (1995-12-01)
    Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed
    Bjørn T Moe et al.
    Anticancer research, 29(4), 1047-1052 (2009-05-06)
    Endometrial hyperplasia is a precursor lesion of endometrial carcinoma. Clinical studies of endometrial hyperplasia have shown that levonorgestrel (LNG) is more therapeutically effective than medroxyprogesterone acetate (MPA). The present pharmacological in vitro study was performed to compare progestin effects on
    A Orbo et al.
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 117(7), 972-976 (1997-03-10)
    The development of female steroid hormone-related neoplasms such as gynaecologic and mammary cancers is influenced by hormones administered exogenously. Hormonal contraceptives and hormone replacement therapy both affect the risk of developing cancers in the endometrium, cervix, ovarium, and mammary glands.

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持